Med16 promotes tumour progression and tamoxifen sensitivity by modulating autophagy through the mtor signalling pathway in er-positive breast cancer

HIGHLIGHTS

• who: Han Li and colleagues from the Department of and Thyroid Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China have published the article: MED16 Promotes Tumour Progression and Tamoxifen Sensitivity by Modulating Autophagy through the mTOR Signalling Pathway in ER-Positive Breast Cancer, in the Journal: Life 2022, 1461 of /2022/
• what: The authors demonstrated that the mTOR signalling pathway is regulated by the expression level of in ER+ With the analysis of bioinformatics data and clinical specimens the authors revealed an elevated expression of in luminal subtype tumours. The authors focused . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.